LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Clinical trials for LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise in slowing advanced neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) compared to a placebo. About 298 adults whose cancer worsened after prior treatment will receive either cabozantinib or a placebo pill. The main goal …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could abemaciclib be the next weapon against Hard-to-Treat gut tumors?
Disease control OngoingThis phase 2 trial tests the drug abemaciclib (Verzenio) in 20 patients with advanced gastroenteropancreatic neuroendocrine tumors that have spread, are not responding to treatment, and cannot be surgically removed. The drug works by blocking enzymes that help cancer cells grow. …
Matched conditions: LOCALLY ADVANCED UNRESECTABLE DIGESTIVE SYSTEM NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC